Biostock publishes article about the positive pre-clinical results and coming milestone for Prolight Diagnostics in Q2

Nyheter Prolight Diagnostics Nyheter alla bolag

Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Biostock publishes article about the positive pre-clinical results and coming milestone for Prolight Diagnostics in Q2

Prolight’s CSO reflects on positive pre-clinical results and looks ahead to the next key milestone in Q2:

Read the article here: https://biostock.se/2025/05/prolights-cso-reflects-on-positive-pre-clinical-results-and-looks-ahead-to-key-milestone-in-q2/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.

The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.

Datum	2025-05-28, kl 11:55
Källa	MFN

Bifogade filer

Biostock publishes article about the positive pre-clinical results and coming milestone for Prolight Diagnostics in Q2

LOGGA IN

Prolight Diagnostics

Biostock publishes article about the positive pre-clinical results and coming milestone for Prolight Diagnostics in Q2